• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

E-Module

An HIV and Rehab Resource

  • Français
  • About
    • 1 – What is this resource about and who is it for?
    • 2 – Why was this resource created?
    • 3 – How can this resource be used?
    • 4 – Can this resource be used for teaching?
    • 5 – How was this resource developed?
    • 6 – Who contributed to developing this adapted resource?
    • 7 – Who funded the development of this resource?
    • 8 – Disclaimer
  • Section 1
    • 1.1 How is “rehabilitation” defined in this resource?
    • 1.2 How can rehabilitation help people living with HIV?
    • 1.3 How can the World Health Organization’s “ICF” help us think about rehabilitation for people living with HIV?
    • 1.4 How can the Episodic Disability Model help us think about rehabilitation for people living with HIV?
    • 1.5 Who provides rehabilitation for people living with HIV?
    • 1.6 Do rehabilitation providers need special skills or training to care for people living with HIV? If so, what?
    • 1.7 What roles do rehabilitation providers have related to HIV?
    • 1.8 When is rehabilitation clinical intervention useful along the HIV care continuum?
  • Section 2
    • 2.1 What do rehabilitation professionals need to know about the stages of HIV infection?
    • 2.2 What do rehabilitation providers need to know about CD4 count and viral load?
    • 2.3 What is the impact of HIV on body systems and why does this matter for rehabilitation providers?
    • 2.4 Who might rehabilitation providers treat?
    • 2.5 What do rehabilitation providers need to know about antiretroviral therapies?
  • Section 3
    • 3.1 What are the rehabilitation interventions that address impairments common among people living with HIV?
    • 3.2 What are the rehabilitation interventions that can address the activity limitations and participation restrictions common among people living with HIV?
    • 3.3 More information on the rehabilitation interventions available for people living with HIV
    • 3.4 – What do rehabilitation providers need to know about their patients’ beliefs and use of traditional healers, spiritual leaders and alternative therapies outside the formal medical system?
  • Section 4
    • 4.1: Intersectionality Theory in the Context of Rehabilitation
    • 4.2: Children and Youth
    • 4.3: HIV and Aging
    • 4.4: Substance Use
    • 4.5: Trauma
    • 4.6: Racialized Populations
    • 4.7: Indigenous Populations
    • 4.8: HIV, Sex and Gender
    • 4.9: HIV and COVID-19
    • 4.10: Is HIV itself a disability?
  • Section 5
    • 5.1 What are outcome measures?
    • 5.2 Why is it important to use outcome measures during rehabilitation with people living with HIV?
    • 5.3 How do rehabilitation providers know if an outcome measure will be useful in practice?
    • 5.4 What are floor and ceiling effects in outcome measurement?
    • 5.5 What is the difference between generic and HIV-specific outcome measures?
    • 5.6 How should you decide which outcome measures to use?
    • 5.7 How do you access a copy of an outcome measure?
    • 5.8 What are rehabilitation-related outcome measures that can be useful for people living with HIV?
  • Case Studies
    • Case #1 – Acute Care, Cardiorespiratory and Neurological
    • Case #2 – Musculoskeletal – Knee Pain
    • Case #3 – Aging, Cognition, Community, Stroke
    • Case #4 – Complex Case – Musculoskeletal, Episodic, Cardiorespiratory
    • Case #5 – Diabetes, Neuropathy, Substance Use
    • Case #6 – Transition from Paediatric to Adult Care
    • Supplemental Case Studies without Leading Questions
Hide Search
Show Search

2.1 What do rehabilitation professionals need to know about the stages of HIV infection?

Rehabilitation providers have a role in caring for people living with HIV throughout the course of the infection and subsequent chronic health condition. In this section, we introduce the stages of HIV infection. To learn more about the role of rehabilitation in HIV disease please see Section 1.7.

2.1.1 Acute Infection

When a person first becomes infected it is called viremia, a term used for all viral infections. During this initial phase, the virus replicates rapidly and people commonly experience flu-like symptoms (e.g. fever, fatigue, aching muscles, headache, and rash). Many of these symptoms can go unrecognized.

A person is most infectious during this phase.

Within the first 2 to 6 weeks, the CD4 count decreases rapidly as the virus attacks these cells.

After 6 to 8 weeks, antibodies are developed as part of the immune response (seroconversion) and the viral load (amount of HIV in the blood) drops.

HIV tests are designed to detect if these antibodies are present so a person will have a positive HIV test after seroconversion. Different tests also have different testing windows.1,2

The antibodies for HIV are measurable within 3 months of initial infection for most people. During this time, people may not show any signs of being infected.

1 Government of Canada. Types of HIV Tests.

2 CATIE. HIV Testing Technologies.

2.1.2 Clinical latency

During the clinical latency phase, a person infected with HIV may be symptom free and unaware of their HIV status. This phase varies in length and depends on many factors including pre-existing health status, genetic factors, social determinants of health, and stress.

When the CD4 count drops below 200 cells/mm3, the immune system struggles to fight off the virus, the viral load increases and the body is susceptible to opportunistic infections and HIV-related illnesses.

If the person is not treated with HIV medications at this point (i.e., once the CD4 count has dropped below 200 cells/mm3), the natural history of HIV has shown high mortality levels within 2 to 3 years.

It is important to note, however, that most individuals with HIV can now have a life expectancy that is close to normal if they can access and adhere to lifelong antiretroviral therapy.1

1 United Nations Program on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2013. November 2013.

2.1.3 AIDS (Acquired Immunodeficiency Syndrome)

In advanced stages of HIV, a person may be diagnosed with Acquired Immunodeficiency Syndrome (AIDS).

AIDS is not a disease. AIDS is a category developed in 1993 by the U.S. Centers for Disease Control as a way of identifying advanced HIV progression.1 A person is said to have AIDS if:

  • they are HIV-positive, and
  • their CD4 count is less than 200 cells/mm3, or
  • they have one of the 26 clinical conditions that are considered to be AIDS-defining

Given advances in HIV care, the AIDS classification system is used less often.

Rehabilitation providers should focus on addressing the challenges (i.e., impairments, activity limitations, participation restrictions) resulting from HIV and/or HIV-related illnesses (which may or may not constitute “AIDS”). See Section 1.3 for further details.

1 Centers for Disease Control. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. December 1992.

Primary Sidebar

Copyright © 2025 · Realize Canada